India develops new vaccine to control classical
The Indian Institute of Veterinary Research (IVRI) of the Indian
Council of Agricultural Research (ICAR) developed a new vaccine to control
classical swine fever. A report published in government news agencies stated that
a new vaccine will be cheaper and more effective.
Classical Swine Fever Vaccine (CSFV) is the most common disease in
pigs that causes a high mortality rate of swine in India. India has been using
UK based swine fever vaccine since 1964. The traditional vaccine is responsible
for sacrificing a large number of rabbits.
Benefits of indigenous
• This vaccine will help
to protect rabbits as currently lapinized CSF (Classical Swine Fever) vaccines
are manufactured from rabbits.
• This new vaccine will provide two years of immunization capacity, while the
existing vaccines only provide 3 to 6 months of immunization capacity.
• IVRI developed a cell culture vaccine to do away the sacrificing of rabbits.
The new vaccine will be ready for commercial production within a year.
• The report said that the new vaccine will be a part of the government’s One
Classical Swine Fever (CSF) is one of the biggest pigs’ diseases
in India. It causes a loss of about 400 crores of rupees per year in India.
This has led to a decrease in the population of pigs in 2019. India currently
requires 22 million doses of the CSF (Classical Swine Fever) vaccine every
year. However, currently, only 1.2 million doses are being produced. The reason
behind its less production is that only 50 doses can be prepared from the the spleen of a rabbit.
What is Classical Swine Fever (CSF)?
Hog Cholera or Classical swine fever (CSF) is a contagious viral
disease of domestic and wild swine. It happens due to the viruses that bring
viral diarrhea in pigs and ailments in sheep. World Organisation for Animal
Health has mentioned only one type of CSF virus. However, the disease does not
harm humans but all-important precautions are advised to follow.